Article
Case Study Using Nebulized Isomerized Linoleic Acid (LA) for Outpatient Treatment of Symptomatic COVID-19.
2020-11-23
Abstract excerpt
We report the resolution of COVID-19 related symptoms in 6 days in two moderate to high risk COVID-19 patients (CDC, 2020) treated with nebulized 0.5 ml 11 mM LA every 4 hours around the clock for 7 days in an outpatient setting. The lipid potassium salt LA is Generally Recognized As Safe (GRAS) by the FDA (Food Additive). We report that in vitro testing of LA 4.4-50.2 mM showed 99% kill-rate of COVID-19 in 2 minu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cf8a2bf2-a784-5a56-8848-d2d5ed81eb6e
- DOI
- 10.2139/ssrn.3733231
